Federal Court in California Awards AngioScore $20 Million Plus Disgorgement in Breach of Fiduciary Duty Case
GLYSURE SECURES CE MARK AND LAUNCHES WORLD'S FIRST CONTINUOUS INTRAVASCULAR GLUCOSE MONITORING SYSTEM
Galderma Receives FDA Approval to Market Restylane® Lyft with Lidocaine to Correct Age Related Volume Loss in the Cheek Area
Novartis Pharmaceuticals launches the first app for visually impaired people for use with the Apple Watch and other smart watches
ISELIN, N.J., July 1, 2015 /PRNewswire/ -- Echo Therapeutics, Inc.
GlySure Secures CE Mark and Launches World's First Continuous Intravascular Glucose Monitoring System
System addresses unmet need for continuous glucose monitoring in the ICU, a potential market in excess of $5 billion ABINGDON, England, July 1, 2015 – GlySure Limited today announced that it...